Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Newborn Foundation Bestows Masimo Corporation CEO With The “Dawn Of Life” Award

October 17, 2014 – 5:00 am | Edit Post

IRVINE, CA–(Marketwired – October 13, 2014) – Highlighted Links Masimo The Newborn Foundation presented Joe Kiani, founder, CEO and Chairman of the Board of

U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical’s ZMapp Ebola Plans

October 17, 2014 – 5:00 am | Edit Post

West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More

October 17, 2014 – 3:30 am | Edit Post

From big venture firms to tiny genomics startups, we’ve got plenty to round up this week—beyond biotech, too, as the San Francisco Giants head east to the biggest baseball rodeo for the…
[[Click headline to continue reading.]]

VC Funding Still Robust as Year-to-Date Total Exceeds 2013

October 16, 2014 – 9:01 pm | Edit Post

Venture capital activity is down from a 13-year high during the second quarter, but a new MoneyTree Report released today shows that venture funding was still going strong in the three months that…

[[Click headline to continue reading.]]

U of Minnesota denies (sort of) Ebola can be airborne

October 16, 2014 – 8:16 pm | Edit Post

Article stating that airborne transmission is possible was just a guest commentary, the university said.

NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results

October 16, 2014 – 1:30 pm | Edit Post

SAN DIEGO, CA–(Marketwired – Oct 16, 2014) – NuVasive, Inc. ( NASDAQ : NUVA ), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place on Thursday, October 30, 2014, after the close of the market.

Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year

October 16, 2014 – 11:07 am | Edit Post

In a year of big venture capital numbers, Canaan Partners has provided one of the biggest. The Westport, CT-based firm announced Thursday a $675 million fund, its tenth. As with its previous general…

[[Click headline to continue reading.]]

Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego

October 16, 2014 – 10:33 am | Edit Post

NEW YORK, Oct. 16, 2014 /PRNewswire/ — Curtis & Coulter LLC, a new specialty life science events organizer is under 3 weeks away from hosting their co-located Bioequivalence: Intersection Between Science & Regulatory Summit and Oral Drug Formulation Innovations Summit taking place on November 5-6 2014 at the Westin San Diego, CA.

Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego

October 16, 2014 – 10:33 am | Edit Post

NEW YORK, Oct. 16, 2014 /PRNewswire/ — Curtis & Coulter LLC, a new specialty life science events organizer is under 3 weeks away from hosting their co-located Bioequivalence: Intersection Between Science & Regulatory Summit and Oral Drug Formulation Innovations Summit taking place on November 5-6 2014 at the Westin San Diego, CA.

November’s events are specifically designed to unify and assist drug development organizations in streamlining the bioequivalence testing process, as well as optimizing formulation development approaches for oral drug products. This will in turn have a positive knock-on effect on approval rates of much-needed future drug products.

“We are delighted that multiple leading players within the global life sciences community share this vision and are thrilled that attendees will be joining us in San Diego from as far afield as China, India, Taiwan, Czech Republic, Brazil, Germany and Italy,” stated Mark Coulter, CEO of Curtis & Coulter LLC. “It’s good to know the global life science community is committed to unite and work towards overcoming bioequivalence and formulation development challenges in order to ensure that faster, safer, much-needed drug products are readily available,” he added.

The two events will include key presentations from Pfizer, Merck, GlaxoSmithKline, Johnson & Johnson amongst other leading drug development organizations. Additionally presenters will include the FDA, and a number of other global regulatory agencies. You can find out more information including program details and registration options by visiting www.curtiscoulter.com

About Curtis & Coulter LLC

Curtis & Coulter specialize in researching and developing cutting-edge events for the life sciences sector. Each event is designed to bring together industry professionals in a unique format for collaborative learning and networking. They provide an unmatched, innovative user experience to exchange ideas, gain advanced industry knowledge and benchmark with like-minded peers through interactive platforms.

Media Contact:Lauren LoreyMedia@curtiscoulter.com
 631-921-9175
SOURCE Curtis & Coulter LLC

Changing Lives: Carol Vassiliadis Names Hospital with $8.5 Million to Jacobs Medical Center

October 16, 2014 – 6:00 am | Edit Post

Carol Vassiliadis did not attend college at the University of California, San Diego. Her two children did not go to UC San Diego. Her late husband, who battled cancer over a decade ago, was not treated at UC San Diego Moores Cancer Center. Yet, Vassiliadis has dedicated innumerable hours and considerable resources to the campus, including gifts totaling $8.5 million to the future UC San Diego Jacobs Medical Center. In honor of her support, the new facility—to be opened in 2016—will be home to the “A. Vassiliadis Family Hospital for Advanced Surgery.” A portion of Vassiliadis’ support was also matched by an anonymous donor as part of a Jacobs Medical Center Challenge grant, for a total of $12 million in gifts.